The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Fat and Beyond: The Diverse Biology of PPARγ
Abstract
The nuclear receptor PPARgamma is a ligand-activated transcription factor that plays an important role in the control of gene expression linked to a variety of physiological processes. PPARgamma was initially characterized as the master regulator for the development of adipose cells. Ligands for PPARgamma include naturally occurring fatty acids and the thiazolidinedione (TZD) class of antidiabetic drugs. Activation of PPARgamma improves insulin sensitivity in rodents and humans through a combination of metabolic actions, including partitioning of lipid stores and the regulation of metabolic and inflammatory mediators termed adipokines. PPARgamma signaling has also been implicated in the control of cell proliferation, atherosclerosis, macrophage function, and immunity. Here, we review recent advances in our understanding of the diverse biological actions of PPARgamma with an eye toward the expanding therapeutic potential of PPARgamma agonist drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as PPAR-γ, expressed in adipose tissue, enhances insulin sensitivity, while PPAR-δ, predominantly found in skeletal muscle, supports oxidative metabolism and promotes mitochondrial biogenesis”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“Both PPAR-γ and PPAR-δ activation may prove beneficial in maintaining metabolic flexibility during aging”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“as PPAR-γ, expressed in adipose tissue, enhances insulin sensitivity, while PPAR-δ, predominantly found in skeletal muscle, supports oxidative metabolism and promotes mitochondrial biogenesis”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [113]
In the citing paper
“the insulinsensitizing effects of thiazolidinediones, a class of PPARg ligands, are used for the treatment of type 2 diabetes mellitus (Tontonoz and Spiegelman, 2008;Hong et al., 2018).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
In the citing paper
“In addition, PPARg exerts considerable effects on lipid and glucose metabolism and insulin sensitivity (Tontonoz and Spiegelman, 2008).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
In the citing paper
“PPARs are activated by a variety of molecules and act mainly as sensors for fatty acids and fatty acid-derived metabolites (Lefebvre et al., 2006;Tontonoz and Spiegelman, 2008;Neels and Grimaldi, 2014).”
From The Peroxisome Proliferator–Activated Receptor (PPAR)-γ Antagonist 2-Chloro-5-Nitro-N-Phenylbenzamide (GW9662) Triggers Perilipin 2 Expression via PPARδ and Induces Lipogenesis and Triglyceride Accumulation in Human THP-1 Macrophages (2020) · cites this paper as Tontonoz and Spiegelman, 2008
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Self-citationXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationLehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
Research works printed but not linked: 7
- Kletzien R, 1992, Mol. Pharmacol., 42, 558
- Harris P, 1994, Mol. Pharmacol., 45, 439
- 10.1210/me.11.6.779 · DOI
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1016/j.expneurol.2006.04.006 · DOI
- 10.1210/en.142.7.3125 · DOI
- Suh N, 1999, Cancer Res., 59, 5671
Cited by
Sorted by citations
Items 301–400 of 1,001
Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation
Jiang, X., Ye, X., Guo, W., Lu, H., & Gao, Z. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0066 · Cited by 102
Adipose tissue inflammation in glucose metabolism
Kammoun, H. L., Kraakman, M. J., & Febbraio, M. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9274-4 · Cited by 101
Hall, J. A., Ramachandran, D., Roh, H. C., DiSpirito, J. R., Belchior, T., Zushin, P. H., Palmer, C., Hong, S., Mina, A. I., Liu, B., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.08.016 · Cited by 102
Self-citationBerry, D. C., & Noy, N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.07.002 · Cited by 100
Redox Mechanisms in Regulation of Adipocyte Differentiation: Beyond a General Stress Response
Liu, G., Chan, E. C., Higuchi, M., Dusting, G. J., & Jiang, F. (2012) · Cells · doi:10.3390/cells1040976 · Cited by 101
Lyssimachou, A., Santos, J. G., André, A., Soares, J., Lima, D., Guimarães, L., Almeida, C. M. R., Teixeira, C. F. C. P., Castro, L. F. C., & Santos, M. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143911 · Cited by 107
Choi, S., Kim, E. S., Jung, J., Marciano, D. P., Jo, A., Koo, J. Y., Choi, S. Y., Yang, Y. R., Jang, H., Kim, E., et al. (2016) · Diabetes · doi:10.2337/db15-1382 · Cited by 101
PPARγand Its Role in Cardiovascular Diseases
Chandra, M., Miriyala, S., & Panchatcharam, M. (2017) · PPAR Research · doi:10.1155/2017/6404638 · Cited by 101
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Napoli, N., Strollo, R., Paladini, A., Briganti, S., Pozzilli, P., & Epstein, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/690783 · Cited by 105
Park, U., Jeong, H.-S., Jo, E.-Y., Park, T., Yoon, S. K., Kim, E.-J., Jeong, J.-C., & Um, S. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf204514a · Cited by 100
Lee, H. S., Lim, S.-M., Jung, J. I., Kim, S. M., Lee, J. K., Kim, Y. H., Cha, K. M., Oh, T. K., Moon, J. M., Kim, T. Y., et al. (2019) · Nutrients · doi:10.3390/nu11102475 · Cited by 99
Epigenetic codes of PPARγ in metabolic disease
Sugii, S., & Evans, R. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.007 · Cited by 102
Deol, P., Evans, J. R., Dhahbi, J. M., Chellappa, K., Han, D. S. C., Spindler, S. R., & Sladek, F. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132672 · Cited by 103
Obesity and endocrine-disrupting chemicals
Amato, A. A., Wheeler, H. B., & Blumberg, B. (2021) · Endocrine Connections · doi:10.1530/ec-20-0578 · Cited by 109
Functional implications of genetic variation in human PPARγ
Jeninga, E. H., Gurnell, M., & Kalkhoven, E. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.04.005 · Cited by 102
The Insulin Receptor: A New Target for Cancer Therapy
Malaguarnera, R., & Belfiore, A. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00093 · Cited by 98
Dual Effects of Lipid Metabolism on Osteoblast Function
Alekos, N. S., Moorer, M. C., & Riddle, R. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.578194 · Cited by 101
Nerurkar, P. V., Lee, Y.-K., & Nerurkar, V. R. (2010) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-10-34 · Cited by 97
Zhang, B., Tsai, P.-C., Gonzalez-Celeiro, M., Chung, O., Boumard, B., Perdigoto, C. N., Ezhkova, E., & Hsu, Y. (2016) · Genes & Development · doi:10.1101/gad.285429.116 · Cited by 101
Berry, D. C., Jiang, Y., & Graff, J. M. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.05.001 · Cited by 100
Endocrine Disrupting Chemicals’ Effects in Children: What We Know and What We Need to Learn?
Predieri, B., Iughetti, L., Bernasconi, S., & Street, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911899 · Cited by 91
Sex differences in lipid metabolism and metabolic disease risk
Sugiyama, M. G., & Agellon, L. B. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-067 · Cited by 98
Woldt, E., Terrand, J., Mlih, M., Matz, R. L., Bruban, V., Coudane, F., Foppolo, S., Asmar, Z. E., Chollet, M. E., Ninio, E., et al. (2012) · Nature Communications · doi:10.1038/ncomms2087 · Cited by 100
Regulation of lipid droplet-associated proteins by peroxisome proliferator-activated receptors
Rodriguez, M. A. D. L. R., & Kersten, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.007 · Cited by 97
Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
Zgajnar, N. R., Leo, S. A. D., Lotufo, C. M., Erlejman, A. G., Piwien‐Pilipuk, G., & Galigniana, M. D. (2019) · Biomolecules · doi:10.3390/biom9020052 · Cited by 95
Controlling low rates of cell differentiation through noise and ultrahigh feedback
Ahrends, R., Ota, A., Kovary, K. M., Kudo, T., Park, B. O., & Teruel, M. N. (2014) · Science · doi:10.1126/science.1252079 · Cited by 90
Söhle, J., Knott, A., Holtzmann, U., Siegner, R., Grönniger, E., Schepky, A. G., Gallinat, S., Wenck, H., Stäb, F., & Winnefeld, M. (2009) · Nutrition & Metabolism · doi:10.1186/1743-7075-6-20 · Cited by 94
Koppaka, S., Kehlenbrink, S., Carey, M., Li, W., Sánchez, E., Lee, D.-E., Lee, H., Chen, J., Carrasco, E., Kishore, P., et al. (2013) · Diabetes · doi:10.2337/db12-0868 · Cited by 90
Obesity-Induced Changes in Bone Marrow Homeostasis
Beňová, A., & Tencerová, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00294 · Cited by 102
Wnt Signaling in Pancreatic Islets
Liu, Z., & Habener, J. F. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-3271-3_17 · Cited by 94
Maintaining hepatocyte differentiation in vitro through co-culture with hepatic stellate cells
Krause, P., Saghatolislam, F., Koenig, S., Unthan‐Fechner, K., & Probst, I. (2009) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-008-9166-1 · Cited by 93
Shin, E., Choi, K.-M., Yoo, H., Lee, C., Hwang, B. Y., & Lee, M. K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.1610 · Cited by 93
Lee, W. S., & Kim, J. (2015) · PPAR Research · doi:10.1155/2015/271983 · Cited by 97
Distinct functions ofUlk1andUlk2in the regulation of lipid metabolism in adipocytes
Ro, S.-H., Jung, C. H., Hahn, W. S., Xu, X., Kim, Y.-M., Yun, Y. S., Park, J.-M., Kim, K. H., Seo, M., Ha, T.-Y., et al. (2013) · Autophagy · doi:10.4161/auto.26563 · Cited by 93
Redox Characterization of the FeS Protein MitoNEET and Impact of Thiazolidinedione Drug Binding
Bak, D. W., Zuris, J. A., Paddock, M. L., Jennings, P. A., & Elliott, S. J. (2009) · Biochemistry · doi:10.1021/bi9016445 · Cited by 92
Control of ovulation in mice by progesterone receptor-regulated gene networks
Kim, J., Bagchi, I. C., & Bagchi, M. K. (2009) · Molecular Human Reproduction · doi:10.1093/molehr/gap082 · Cited by 92
Zhang, Q., Ramlee, M. K., Brunmeir, R., Villanueva, C. J., Halperin, D., & Xu, F. (2012) · Cell Cycle · doi:10.4161/cc.22224 · Cited by 94
Lefèvre, L., Galès, A., Olagnier, D. P., Bernad, J., Perez, L., Burcelin, R., Valentin, A., Auwerx, J. H., Pipy, B., & Coste, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012828 · Cited by 91
On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens
Janesick, A., Dimastrogiovanni, G., Vanek, L., Boulos, C., Chamorro-García, R., Tang, W., & Blumberg, B. (2016) · Environmental Health Perspectives · doi:10.1289/ehp.1510352 · Cited by 89
PFAS and Potential Adverse Effects on Bone and Adipose Tissue through Interactions with PPARγ
Kirk, A. B., Michelsen-Correa, S., Rosen, C., Martin, C. F., & Blumberg, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab194 · Cited by 90
Kiselyuk, A., Lee, S., Farber-Katz, S., Zhang, M., Athavankar, S., Cohen, T., Pinkerton, A. B., Ye, M., Bushway, P., Richardson, A. D., et al. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.05.014 · Cited by 96
Gao, P., Wang, L., Yang, N., Wen, J., Zhao, M., Su, G., Zhang, J., & Weng, D. (2019) · Environment International · doi:10.1016/j.envint.2019.105328 · Cited by 93
Role of PPARs in inflammatory processes associated with metabolic syndrome (Review)
Eduardo Fuentes, Q., Guzmán, L., Moore‐Carrasco, R., & Palomo, I. F. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1714 · Cited by 89
Kleinhenz, J., Kleinhenz, D. J., You, S., Ritzenthaler, J. D., Hansen, J. M., Archer, D. R., Sutliff, R. L., & Hart, C. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00148.2009 · Cited by 91
Tu, Y., Liu, J., Kong, D., Guo, X., Li, J., Long, Z., Peng, J., Wang, Z., Wu, H., Liu, P., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.03.014 · Cited by 89
Parham, K. A., Zebol, J. R., Tooley, K. L., Sun, W. Y., Moldenhauer, L. M., Cockshell, M. P., Gliddon, B. L., Moretti, P. A., Tigyi, G., Pitson, S. M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-261289 · Cited by 89
Yan, Z., Zhang, H., Maher, C., Arteaga‐Solis, E., Champagne, F. A., Wu, L., McDonald, J. D., Yan, B., Schwartz, G. J., & Miller, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110706 · Cited by 89
Grimaldi, M., Boulahtouf, A., Delfosse, V., Thouënnon, E., Bourguet, W., & Balaguer, P. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00062 · Cited by 89
Docosahexaenoic acid neurolipidomics
Niemoller, T. D., & Bazan, N. G. (2009) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.09.005 · Cited by 91
Park, B. O., Ahrends, R., & Teruel, M. N. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.038 · Cited by 86
Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue
Taeye, B. M. D., Morisseau, C. H. P., Coyle, J., Covington, J. W., Luria, A., Yang, J., Murphy, S. B., Friedman, D. B., Hammock, B. D., & Vaughan, D. E. (2009) · Obesity · doi:10.1038/oby.2009.227 · Cited by 89
Obestatin as a regulator of adipocyte metabolism and adipogenesis
Gurriarán‐Rodríguez, U., Al–Massadi, O., Roca-Rivada, A., Crujeiras, A. B., Gallego, R., Pardo, M., Seoane, L. M., Pazos, Y., Casanueva, F. F., & Camiña, J. P. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01192.x · Cited by 90
The Krüppel-Like Factors and Control of Energy Homeostasis
Hsieh, P. N., Fan, L., Sweet, D. R., & Jain, M. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00151 · Cited by 85
Thangavel, N., Bratty, M. A., Javed, S. A., Ahsan, W., & Alhazmi, H. A. (2017) · International Journal of Medicinal Chemistry · doi:10.1155/2017/1069718 · Cited by 89
Fontanesi, L., Galimberti, G., Calò, D. G., Fronza, R., Martelli, P. L., Scotti, E., Colombo, M., Schiavo, G., Casadio, R., Buttazzoni, L., et al. (2012) · Journal of Animal Science · doi:10.2527/jas.2011-4797 · Cited by 87
Choi, S., Kim, E. S., Koh, M., Lee, S., Lim, D., Yang, Y. R., Jang, H., Seo, K., Min, S., Lee, I. H., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.566794 · Cited by 86
PPARγ Regulates Mouse Meibocyte Differentiation and Lipid Synthesis
Jester, J. V., Potma, E. O., & Brown, D. J. (2016) · The Ocular Surface · doi:10.1016/j.jtos.2016.08.001 · Cited by 88
Genomic Insights Into the Multiple Factors Controlling Abdominal Fat Deposition in a Chicken Model
Abdalla, B. A., Chen, J., Nie, Q., & Zhang, X. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00262 · Cited by 86
Osteoblast-Targeted suppression of PPARγ increases osteogenesis through activation of mTOR signaling
Sun, H., Kim, J. K., Mortensen, R. M., Mutyaba, L. P., Hankenson, K. D., & Krebsbach, P. H. (2013) · Stem Cells · doi:10.1002/stem.1455 · Cited by 89
The impact of PPARα activation on whole genome gene expression in human precision cut liver slices
Janssen, A. W. F., Betzel, B., Stoopen, G. M., Berends, F. J., Janssen, I. M. C., Peijnenburg, A., & Kersten, S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1969-3 · Cited by 85
Ottestad, I. O., Hassani, S., Borge, G. I. A., Köhler, A., Vogt, G., Hyötyläinen, T., Orešič, M., Brønner, K. W., Holven, K. B., Ulven, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042550 · Cited by 88
DEPTOR at the Nexus of Cancer, Metabolism, and Immunity
Caron, A., Briscoe, D. M., Richard, D., & Laplante, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00064.2017 · Cited by 87
Jmjd3-Mediated H3K27me3 Dynamics Orchestrate Brown Fat Development and Regulate White Fat Plasticity
Pan, D., Huang, L., Zhu, L. J., Zou, T., Ou, J., Zhou, W., & Wang, Y. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.11.002 · Cited by 83
Recurrent activating mutations of PPARγ associated with luminal bladder tumors
Rochel, N., Krucker, C., Coutos-Thévenot, L., Ősz, J., Zhang, R., Guyon, E., Zita, W., Vanthong, S., Hernandez‐Alba, O., Bourguet, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08157-y · Cited by 84
Profiling and Identification of Small rDNA-Derived RNAs and Their Potential Biological Functions
Wei, H., Zhou, B. Z., Zhang, F., Tu, Y., Hu, Y., Zhang, B., & Zhai, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056842 · Cited by 87
PPAR-γ Activation As an Anti-inflammatory Therapy for Respiratory Virus Infections
Bassaganya-Riera, J., Song, R., Roberts, P. C., & Hontecillas, R. (2010) · Viral Immunology · doi:10.1089/vim.2010.0016 · Cited by 83
Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β1signalling
Mutlu, G. M., Budinger, G. R. S., Wu, M., Lam, A. P., Zirk, A., Rivera, S., Urich, D., Chiarella, S. E., Go, L. H. T., Ghosh, A. K., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200717 · Cited by 83
Antidiabetic plant-derived nutraceuticals: a critical review
Naveen, J., & Baskaran, V. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1552-6 · Cited by 88
Bouguen, G., Langlois, A., Djouina, M., Branche, J., Koriche, D., Dewaeles, E., Mongy, A., Auwerx, J. H., Colombel, J., Desreumaux, P., et al. (2014) · Gut · doi:10.1136/gutjnl-2014-307618 · Cited by 81
Liu, W., Struik, D., Nies, V. J. M., Jurdzinski, A., Harkema, L., de Bruin, A., Verkade, H. J., Downes, M., Evans, R. M., van Zutphen, T., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525093113 · Cited by 83
Unraveling the role of FoxOs in bone—Insights from mouse models
Almeida, M. (2011) · Bone · doi:10.1016/j.bone.2011.05.023 · Cited by 85
Yamagishi, S., Nakamura, K., & Matsui, T. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.006 · Cited by 81
Biemann, R., Santos, A. N., Santos, A. N., Riemann, D., Knelangen, J. M., Blüher, M., Koch, H. M., & Fischer, B. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.028 · Cited by 81
Hu, W., Jia, Y., Kang, Q., Peng, H., Ma, H., Zhang, S., Hiromori, Y., Kimura, T., Nakanishi, T., Zheng, L., et al. (2019) · Environmental Health Perspectives · doi:10.1289/ehp5039 · Cited by 82
Duszka, K., Gregor, A., Guillou, H., König, J. S., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071708 · Cited by 86
Grünberg, J. R., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511964 · Cited by 78
Li, Y., Gao, S., Shi, S., Xiao, D., Peng, S., Gao, Y., Zhu, Y. J., & Lin, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00614-6 · Cited by 82
The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 81
Transgenerational inheritance of prenatal obesogen exposure
Janesick, A., Shioda, T., & Blumberg, B. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.002 · Cited by 83
Chen, Z., Yu, H., Shi, X. D., Warren, C. R., Lotta, L. A., Friesen, M., Meissner, T. B., Langenberg, C., Wabitsch, M., Wareham, N. J., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315246 · Cited by 77
Koppen, A., Houtman, R., Pijnenburg, D., Jeninga, E. H., Ruijtenbeek, R., & Kalkhoven, E. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900209-mcp200 · Cited by 77
Shoucri, B. M., Martinez, E. S., Abreo, T. J., Hung, V. T., Moosová, Z., Shioda, T., & Blumberg, B. (2017) · Endocrinology · doi:10.1210/en.2017-00348 · Cited by 78
Anti-obesity molecular mechanism of soy isoflavones: weaving the way to new therapeutic routes
Wang, S., Wang, Y., Pan, M., & Ho, C.-T. (2017) · Food & Function · doi:10.1039/c7fo01094j · Cited by 78
Huang, Q., Ma, C., Chen, L., Luo, D., Chen, R., & Liang, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00370 · Cited by 78
Aprile, M., Cataldi, S., Ambrosio, M. R., D’Esposito, V., Lim, K., Dietrich, A., Blüher, M., Savage, D. B., Formisano, P., Ciccodicola, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.035 · Cited by 82
The Influence of Dietary Interventions on Arterial Stiffness in Overweight and Obese Subjects
Stanek, A., Grygiel‐Górniak, B., Brożyna-Tkaczyk, K., Myśliński, W., Cholewka, A., & Zolghadri, S. (2023) · Nutrients · doi:10.3390/nu15061440 · Cited by 82
Ji, C., & Zhang, J. Z. H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja807374x · Cited by 77
Kang, S., Tsai, L. T.-Y., Zhou, Y., Evertts, A. G., Xu, S., Griffin, M. J., Issner, R., Whitton, H. J., Garcia, B. A., Epstein, C. B., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3080 · Cited by 76
Liu, M.-J., Bao, S., Bolin, E. R., Burris, D. L., Xu, X., Sun, Q., Killilea, D. W., Shen, Q., Ziouzenkova, O., Belury, M. A., et al. (2013) · Journal of Nutrition · doi:10.3945/jn.113.175158 · Cited by 80
Wei, J., Zhu, H., Komura, K., Lord, G., Tomčík, M., Wang, W., Doniparthi, S., Tamaki, Z., Hinchcliff, M., Distler, J. H. W., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202716 · Cited by 77
Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
Consoli, A., & Formoso, G. (2013) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12101 · Cited by 76
A comprehensive review on high -fat diet-induced diabetes mellitus: an epigenetic view
Prasad, M., Rajagopal, P., Devarajan, N., Veeraraghavan, V. P., Palanisamy, C. P., Cui, B., Patil, S., & Jayaraman, S. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109037 · Cited by 83
Li, X., Pham, H., Janesick, A., & Blumberg, B. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1205383 · Cited by 76
The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Smith, N. J., Stoddart, L. A., Devine, N. M., Jenkins, L., & Milligan, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012849 · Cited by 79
Structural basis for specific ligation of the peroxisome proliferator-activated receptor δ
Wu, C.-C., Baiga, T. J., Downes, M., Clair, J. J. L., Atkins, A. R., Richard, S. B., Fan, W., Stockley-Noel, T. A., Bowman, M. E., Noel, J. P., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621513114 · Cited by 76
Li, Y., & Teng, C. (2014) · Journal of drug targeting · doi:10.3109/1061186x.2014.928715 · Cited by 75
Garaulet, M., Smith, C. E., Hernández‐González, T., Lee, Y., & Ordovás, J. M. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100437 · Cited by 75
Chacko, B. K., Scott, D. W., Chandler, R. T., & Patel, R. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.247981 · Cited by 75
Poly(ADP-Ribose)Polymerase-1 (PARP1) Controls Adipogenic Gene Expression and Adipocyte Function
Erener, S., Hesse, M., Kostadinova, R. M., & Hottiger, M. O. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1163 · Cited by 79
Yuan, G., Chen, X., & Li, D. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505050c · Cited by 76
Metadata
- Authors
- Tontonoz, P., & Spiegelman, B. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Harvard University (US)
- Venue
- Annual Review of Biochemistry
- Publisher
- Annual Reviews
- Published
- 2008-06-01
- Volume
- 77
- Issue
- 1
- Pages
- 289-312
- ISSN
- 0066-4154 (ISSN-L)
- 1545-4509
- OpenAlex
- W2097511872
- Cited by
- 2,085
- References
- 173
- Citations by year
- 2026: 79 · 2025: 100 · 2024: 104 · 2023: 103 · 2022: 111 · 2021: 106 · 2020: 105 · 2019: 108 · 2018: 110 · 2017: 112 · 2016: 135 · 2015: 125 · 2014: 154 · 2013: 160 · 2012: 149
- FWCI
- 8.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Heart, Lung, and Blood Institute (R01HL066088, HL66088)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK 3140)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- PPARγ, nuclear receptors, transcriptional regulation, adipose tissue development, thiazolidinediones, insulin sensitivity, adipokines, lipid partitioning, atherosclerosis, macrophage function, immunity, cell proliferation, PPARγ agonists, antidiabetic drugs
- MeSH terms
- Animals, Cell Nucleus, Humans, Inflammation, Insulin Resistance, Macrophages, Models, Biological, Models, Molecular, Neoplasms, Protein Conformation, Protein Structure, Tertiary, Adipocytes, Thiazolidinediones, PPAR gamma, Adipogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
